Peter Kempler
Overview
Explore the profile of Peter Kempler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
105
Citations
2288
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bordacs B, Varkonyi A, Valkusz Z, Nyiraty S, Posa A, Menyhart A, et al.
Int J Mol Sci
. 2025 Mar;
26(5).
PMID: 40076685
The present study was conducted in type 1 diabetic (T1DM) patients to evaluate the metabolic and glycemic control as well as the manifestations of neuropathy. The impact of continuous glucose...
2.
3.
Esze R, Barna S, Fulop P, Kempler P, Miko M, Pall D, et al.
Diabetol Metab Syndr
. 2024 Aug;
16(1):211.
PMID: 39210480
Background: In order to investigate microvascular complications in metabolic diseases, we aimed to investigate cerebral and peripheral microcirculation in relation to peripheral neuropathy and laboratory biomarkers in type 2 diabetes...
4.
Czupryniak L, Mosenzon O, Rychlik I, Clodi M, Ebrahimi F, Janez A, et al.
Diabetes Obes Metab
. 2024 Aug;
26(10):4165-4177.
PMID: 39140231
Chronic kidney disease (CKD) affects approximately 13% of people globally, including 20%-48% with type 2 diabetes (T2D), resulting in significant morbidity, mortality, and healthcare costs. There is an urgent need...
5.
Keller N, Zadori J, Lippai B, Szollosi D, Marton V, Wellinger K, et al.
Front Endocrinol (Lausanne)
. 2024 Jul;
15:1386147.
PMID: 39081789
Introduction: A higher incidence of neural dysfunction in people with obesity has been described. We determined the prevalence of neuropathic lesions in obese women and evaluated their potential association with...
6.
Molnar A, Szentpeteri A, Lorincz H, Seres I, Harangi M, Balogh Z, et al.
Rev Cardiovasc Med
. 2024 Jul;
23(5):160.
PMID: 39077619
Background: Diabetic neuropathy (DN) is a very frequent microvascular complication of type 2 diabetes mellitus (T2DM). Obesity and physical inactivity are well-known risk factors for T2DM. Fibroblast growth factor 21...
7.
Abonyi-Toth Z, Rokszin G, Suto G, Fabian I, Kiss Z, Jermendy G, et al.
Cancers (Basel)
. 2024 Jul;
16(13).
PMID: 39001476
(1) Background: Among the chronic complications of type 2 diabetes mellitus, cancer has become the leading cause of death in several countries. Our objective was to determine whether prevalent type...
8.
Janez A, Muzurovic E, Bogdanski P, Czupryniak L, Fabryova L, Fras Z, et al.
Diabetes Ther
. 2024 Jul;
15(9):1865-1892.
PMID: 38990471
The increasing global incidence of obesity and type 2 diabetes mellitus (T2D) underscores the urgency of addressing these interconnected health challenges. Obesity enhances genetic and environmental influences on T2D, being...
9.
Peto A, Toth L, Hernyak M, Lorincz H, Molnar A, Nagy A, et al.
PLoS One
. 2024 Jul;
19(7):e0306482.
PMID: 38959204
Distal sensorimotor polyneuropathy (DSPN) is the earliest detectable and the most frequent microvascular complication in diabetes mellitus. Several studies have previously demonstrated correlations between cardiovascular risk factors in diabetic patients...
10.
Hajdu N, Racz R, Tordai D, Bekeffy M, Vagi O, Istenes I, et al.
Int J Mol Sci
. 2024 Jun;
25(12).
PMID: 38928135
The exact mechanism by which diabetic neuropathy develops is still not fully known, despite our advances in medical knowledge. Progressing neuropathy may occur with a persistently favorable metabolic status in...